An investigation for investors in NASDAQ:CSII shares concerning potential breaches of fiduciary duties by certain directors of Cardiovascular Systems Inc was announced.
Investors who are current long term investors in Cardiovascular Systems Inc (NASDAQ:CSII) shares, have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm for investors in NASDAQ:CSII stocks follows a lawsuit filed against Cardiovascular Systems Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ:CSII stocks, concerns whether certain Cardiovascular Systems directors are liable in connection with the allegations made in that lawsuit. The plaintiff alleges that the defendants issued allegedly false and misleading statements to investors and/or allegedly failed to disclose that Cardiovascular Systems distributed illegal kickbacks to health care providers, that Cardiovascular Systems engaged in the off-label promotion of its medical devices, and that Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices.
On May 31, 2016, NASAQ:CSII shares closed at $16.89 per share.
Those who purchased NASDAQ:CSII shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego